Distinct Impex Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.38 M
as on 21-12-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 11.15%
(FY 2022)
- Profit 56.86%
(FY 2022)
- Ebitda 6.43%
(FY 2022)
- Net Worth 126.42%
(FY 2022)
- Total Assets 127.11%
(FY 2022)
About Distinct Impex
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.38 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Baria and Deepak Dubey serve as directors at the Company.
- CIN/LLPIN
U51909MH2019PTC324647
- Company No.
324647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Distinct Impex Private Limited offer?
Distinct Impex Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Animal Medicines & Health Care, Veterinary Medicines, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Respiratory System Drugs, Anti Asthma Drug, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Distinct Impex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Baria  | Director | 09-Nov-2022 | Current |
| Deepak Dubey | Additional Director | 09-Nov-2022 | Current |
Financial Performance of Distinct Impex.
Distinct Impex Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.15% increase. The company also saw a substantial improvement in profitability, with a 56.86% increase in profit. The company's net worth Soared by an impressive increase of 126.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Distinct Impex?
Unlock access to Distinct Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Distinct Impex?
Unlock and access historical data on people associated with Distinct Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Distinct Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Distinct Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
